Katelyn J. Creasman

Statistics

Publications

Citations

536

H-Index

Active since

2012

Affiliations

UCSF Helen Diller Family Comprehensive Cancer Center(Current)

University of California, San Francisco

Howard Hughes Medical Institute

Katelyn J. Creasman is an author at UCSF Helen Diller Family Comprehensive Cancer Center specializing in cyclin-dependent kinase inhibitors, oncogenic signaling pathways, and oncology.

Publications per year

2012–2015

Publications

MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition

Dai Horiuchi, Leonard Kusdra, Noelle E. Huskey et al. · The Journal of Experimental Medicine · 2012 · 396 citations · Full text

Medicine, Cancer Biology, Oncology +17

Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways

Dai Horiuchi, Noelle E. Huskey, Leonard Kusdra et al. · Proceedings of the National Academy of Sciences · 2012 · 75 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

CDK1 Inhibition Targets the p53-NOXA-MCL1 Axis, Selectively Kills Embryonic Stem Cells, and Prevents Teratoma Formation

Noelle E. Huskey, Tingxia Guo, Kimberley Evason et al. · Stem Cell Reports · 2015 · 65 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

1–3 of 3